Nordic Nanovector ASA NANOV.OL Stock
Nordic Nanovector ASA Price Chart
Nordic Nanovector ASA NANOV.OL Financial and Trading Overview
| Nordic Nanovector ASA stock price | 2.56 NOK |
| Previous Close | 2.55 NOK |
| Open | 2.76 NOK |
| Bid | 2.68 NOK x N/A |
| Ask | 2.69 NOK x N/A |
| Day's Range | 2.63 - 2.9 NOK |
| 52 Week Range | 0.65 - 7.78 NOK |
| Volume | 6.79M NOK |
| Avg. Volume | 2.26M NOK |
| Market Cap | 312.13M NOK |
| Beta (5Y Monthly) | 1.613409 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 NOK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11 NOK |
NANOV.OL Valuation Measures
| Enterprise Value | 197.17M NOK |
| Trailing P/E | N/A |
| Forward P/E | -0.8936877 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.890909 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.644 |
Trading Information
Nordic Nanovector ASA Stock Price History
| Beta (5Y Monthly) | 1.613409 |
| 52-Week Change | -62.50% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.78 NOK |
| 52 Week Low | 0.65 NOK |
| 50-Day Moving Average | 0.93 NOK |
| 200-Day Moving Average | 1.07 NOK |
NANOV.OL Share Statistics
| Avg. Volume (3 month) | 2.26M NOK |
| Avg. Daily Volume (10-Days) | 11.69M NOK |
| Shares Outstanding | 116.04M |
| Float | 95.3M |
| Short Ratio | N/A |
| % Held by Insiders | 51.09% |
| % Held by Institutions | 8.36% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -97.63% |
| Return on Equity (ttm) | -304.60% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -306159008 NOK |
| Net Income Avi to Common (ttm) | -311240992 NOK |
| Diluted EPS (ttm) | -2.96 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 98.72M NOK |
| Total Cash Per Share (mrq) | 0.85 NOK |
| Total Debt (mrq) | 0 NOK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.464 |
| Book Value Per Share (mrq) | 0.55 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -409079008 NOK |
| Levered Free Cash Flow (ttm) | -295513504 NOK |
Profile of Nordic Nanovector ASA
| Country | Norway |
| State | N/A |
| City | Oslo |
| Address | KjelsAsveien 168 B |
| ZIP | 0884 |
| Phone | 47 22 18 33 01 |
| Website | https://www.nordicnanovector.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 18 |
Nordic Nanovector ASA, a biopharmaceutical company, develops therapeutics for hematological cancers in Norway. The company's lead product candidate is Betalutin, a CD37-targeting radioimmunotherapy for the treatment of patients with non-hodgkin lymphoma. Its preclinical development products include Humalutin for treatment of non-Hodgkin's lymphoma; Alpha37, a CD37-targeting radioimmunotherapy for treating chronic lymphatic leukemia; and Multiple fully humanized anti-CD37 antibodies for treatment of haematological cancers and autoimmune diseases. The company is also developing 89Zr-NNV003, a CD37-targeting companion PET diagnostic for detection and dosimetry of CD37 expressing tumors. The company has collaboration agreements with Orano Med; Paul Scherrer Institute; ArevaMed; LegoChem Bio; and Heidelberg Pharma. It also has a research collaboration with the University of Pennsylvania development of a CD37-targeting CAR-T in haematological cancers. The company was formerly known as Nordic Nanovector AS and changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was incorporated in 2009 and is headquartered in Oslo, Norway.
Q&A For Nordic Nanovector ASA Stock
What is a current NANOV.OL stock price?
Nordic Nanovector ASA NANOV.OL stock price today per share is 2.56 NOK.
How to purchase Nordic Nanovector ASA stock?
You can buy NANOV.OL shares on the Oslo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nordic Nanovector ASA?
The stock symbol or ticker of Nordic Nanovector ASA is NANOV.OL.
Which industry does the Nordic Nanovector ASA company belong to?
The Nordic Nanovector ASA industry is Biotechnology.
How many shares does Nordic Nanovector ASA have in circulation?
The max supply of Nordic Nanovector ASA shares is 116.04M.
What is Nordic Nanovector ASA Price to Earnings Ratio (PE Ratio)?
Nordic Nanovector ASA PE Ratio is 0.00000000 now.
What was Nordic Nanovector ASA earnings per share over the trailing 12 months (TTM)?
Nordic Nanovector ASA EPS is 0 NOK over the trailing 12 months.
Which sector does the Nordic Nanovector ASA company belong to?
The Nordic Nanovector ASA sector is Healthcare.